Fingerprint
Dive into the research topics where David S Miller is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Lenvatinib plus pembrolizumab in previously treated advanced endometrial cancer: 5-year outcomes from the randomized, phase 3 Study 309/KEYNOTE-775
Makker, V., Colombo, N., Casado, A., Santin, A. D., Colomba, E., Miller, D. S., Fujiwara, K., Pignata, S., Yonemori, K., Kim, Y. M., Baron-Hay, S., Ray-Coquard, I., Shapira-Frommer, R., Kristeleit, R., Nishio, S., Suzuki, S., Guerra Alía, E. M., Sanli, U. A., Selle, F. & Shikama, A. & 10 others, , Feb 2026, In: Journal for ImmunoTherapy of Cancer. 14, 2Research output: Contribution to journal › Article › peer-review
Open Access -
Comparing Durvalumab, Olaparib, and Cediranib Monotherapy, Combination Therapy, or Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer with Prior Bevacizumab: The Phase II NRG-GY023 Trial
Lee, J. M., Miller, A., Rose, P. G., Alhilli, M., Washington, C., John, V. S., Shah, C. A., Matsuo, K., Siedel, J., Miller, D. S., Hopp, E. E., O’shea, A., Chan, J. K., Bradford, L. S., Morse, C. B., Nagel, C. I., Rodabaugh, K. J., Kohn, E. C., Moore, K. N. & Liu, J. F., Jun 15 2025, In: Clinical Cancer Research. 31, 12, p. 2370-2378 9 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Link opens in a new tab Scopus citations -
Impact of Interruptions in Chemotherapy on Survival for Patients With Metastatic or Recurrent Cervical Cancer
Sinha, R., Portmann-Baracco, A., Gorman, A. R., Stock, E. C., Holloway, S. B., Miller, D. S. & Lea, J. S., Dec 8 2025, In: American Journal of Clinical Oncology: Cancer Clinical Trials. Publish Ahead of PrintResearch output: Contribution to journal › Article › peer-review
-
Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of Chemoradiation Versus Chemotherapy for Locally Advanced Endometrial Carcinoma
Matei, D. E., Enserro, D. M., Randall, M. E., Mutch, D., Small, W., Disilvestro, P. A., Spirtos, N. M., O'Malley, D. M., Cantuaria, G. H., Michelin, D., Waggoner, S., Shahin, M., Guntupalli, S., Lara, O., Ueland, F. R., Warshal, D., Bonebrake, A., Tewari, K. S., Tan, A. & Powell, M. A. & 4 others, , Mar 20 2025, In: Journal of Clinical Oncology. 43, 9, p. 1055-1060 6 p.Research output: Contribution to journal › Article › peer-review
Open Access9 Link opens in a new tab Scopus citations -
Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258
Clements, A., Enserro, D., Strickland, K. C., Previs, R., Matei, D., Mutch, D., Powell, M., Klopp, A., Miller, D. S., Small, W., DiSilvestro, P., Spirtos, N., Cosgrove, C., Sfakianos, G., Liu, J. R., Vargas, R., Shahin, M., Corr, B., Dessources, K. & Ueland, F. & 3 others, , Feb 2025, In: Gynecologic oncology. 193, p. 119-129 11 p.Research output: Contribution to journal › Article › peer-review
Open Access15 Link opens in a new tab Scopus citations